Here are three things to know about the retail giant’s financial results for the three months ended Feb. 28.
1. While Walgreens’ retail sales fell 0.7 percent in the second quarter compared to a year prior, Walgreens saw overall sales grow 12.1 percent to $33 billion.
2. The company’s pharmacy division, which reflected 70.3 percent of sales in the quarter, grew 18.7 percent year over year. Walgreens attributed the increase to higher prescription volume, helped by AllianceRx Walgreens Prime, which is Walgreens’ partnership with Prime Therapeutics. Walgreens’ acquisition of 1,542 Rite Aid stores also led to increased pharmacy sales.
3. Walgreens ended the second quarter of 2018 with GAAP operating income of $2 billion, up 33.9 percent from the same period a year prior.
More articles on business:
Uber Freight launches incentive program to attract drivers
The US, China and tariffs: 7 things to know today
FTC to investigate Facebook’s privacy policies: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
